TP53 and neoplasm: These observations are consistent with previous studies that have shown metabolism-related pathways are enriched in MSI-High p53-WT cells and the presence of p53 is required for tumor cells to adapt to the metabolic changes necessary to tolerate drugs that induce metabolic stress [39,40].